Search

Search Constraints

You searched for: Date 2016 Author/Creator Ponsaerts, Peter

Search Results

1. Immune remodelling of stromal cell grafts in the central nervous system: therapeutic inflammation or (harmless) side‐effect?. (20th June 2016)

2. In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants. (28th March 2016)

3. In Vivo Interleukin‐13‐Primed Macrophages Contribute to Reduced Alloantigen‐Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants. (28th March 2016)

5. Interleukin‐13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages. Issue 12 (29th September 2016)

6. Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model. Issue 1 (December 2016)